FDA Attorneys Navigating FDA Compliance
The Food and Drug Administration regulates more than $2.4 trillion in food, drugs, medical devices, and cosmetics. When the federal government alleges a violation of the Federal Food, Drug, and Cosmetic Act, the consequences extend well beyond administrative inconvenience — they can threaten the survival of a business. FDA investigations and enforcement actions demand command of federal litigation, administrative law, and regulatory science in equal measure.
At Chapman, Dowling & Mallek, FDA-related matters are approached as high-stakes regulatory and enforcement events requiring coordinated legal, scientific, and strategic analysis.
What an “FDA Attorneys” Broadly Entails
An FDA attorney operates at the intersection of complex science and federal administrative law. Their work typically spans:
- Regulatory Counseling: Advising on product classification — the line between a “supplement” and a “drug” carries significant legal and commercial weight.
- Pre-market Submissions: Guiding clients through 510(k) clearances, Premarket Approvals (PMAs), and New Drug Applications (NDAs).
- Compliance Defense: Representing clients during facility inspections and responding to agency observations before exposure escalates.
- Litigation: Defending against seizures, injunctions, and Department of Justice criminal investigations when enforcement moves beyond the agency level.
Common FDA Allegations
Most enforcement actions trace back to deviations in manufacturing or marketing. The most frequently charged violations include:
- Misbranding: Distributing a product with labeling that is false, misleading, or lacks adequate directions for use.
- Adulteration: Producing products under conditions that fail to meet Current Good Manufacturing Practices, or that contain contaminated substances.
- Off-Label Promotion: Marketing an approved drug or device for uses the FDA has not cleared.
- Unapproved New Drugs: Commercializing a substance with implied therapeutic benefits without completing the formal approval process.
Who Investigates FDA Violations?
FDA enforcement is layered across multiple agencies, each with a distinct role:
- FDA Office of Regulatory Affairs (ORA): Field investigators who conduct inspections and collect samples.
- Office of Criminal Investigations (OCI): Federal agents embedded within the FDA who pursue potential felonies and criminal fraud.
- Department of Justice (DOJ): The Consumer Protection Branch handles civil and criminal litigation on the government’s behalf.
- Federal Trade Commission (FTC): Frequently coordinates with the FDA on advertising and marketing claims tied to health products.
The FDA Investigation and Enforcement Process
Enforcement generally follows a defined escalation path:
- Inspection (Form 482): Investigators arrive at a facility to review records and operational processes.
- Observations (Form 483): At the close of an inspection, investigators document perceived compliance gaps.
- Warning Letter: A formal agency notice requiring correction within a specified timeframe.
- Consent Decree: A court-supervised settlement requiring the company to cease specified conduct and fund independent oversight.
- Seizure and Injunction: When the threat is immediate, the FDA can move to seize inventory or shut down operations entirely.
Penalties for FDA Violations
Exposure varies with the severity of the conduct, but consequences routinely include:
- Fines: Civil penalties in the millions.
- Product Recalls: Costly, disruptive removal of inventory from distribution.
- Criminal Charges: Custodial sentences for individuals implicated in fraud.
- Reputational Damage: Erosion of market position and consumer trust that compounds long after the legal matter concludes.
Why You Need an Expert Lawyer for FDA Violations
FDA matters are rarely static. What begins as a regulatory issue can evolve into a civil or criminal enforcement action.
At Chapman, Dowling & Mallek, the focus is on:
- Early intervention during inspections and investigations
- Controlling narrative and regulatory positioning
- Managing parallel agency exposure
- Reducing financial and operational risk
Without experienced counsel, organizations risk compounding exposure through missteps at the earliest stages—when strategic decisions carry the greatest downstream impact.
FDA Defense Matters We Handle
FDA enforcement rarely unfolds as a single event. Most matters escalate through inspections, correspondence, and, in some cases, coordinated civil or criminal action.
At Chapman, Dowling & Mallek, our FDA attorneys’ representation is structured around the specific point of exposure—whether the issue begins with an inspection, a warning letter, or a formal enforcement action.
FDA Inspections, Observations, and Early-Stage Exposure
- FDA Inspection Defense Attorney | What to Do During an FDA Inspection
- FDA Form 483 Attorney | Responding to FDA 483 Observations
- FDA Warning Letter Attorney | How to Respond to an FDA Warning Letter
FDA Investigations and Escalating Enforcement Risk
- FDA Subpoena Attorney | OCI Investigation Defense Lawyer
- FDA Import Alert Attorney | DWPE and Import Alert Removal
FDA Litigation and High-Stakes Enforcement Actions
- FDA Injunction Defense Attorney | Consent Decree and DOJ Defense
- FDA Recall Attorney | Voluntary and FDA-Requested Recall Defense
Industry-Specific FDA Defense
- Compounding Pharmacy and GLP-1 FDA Defense Attorney
- Stem Cell FDA Warning Letter Defense | Regenerative Medicine Attorney
Official Government Sources on FDA Matters
For more information on regulations and enforcement, consult these official sources: